JP2017186337A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017186337A5 JP2017186337A5 JP2017073900A JP2017073900A JP2017186337A5 JP 2017186337 A5 JP2017186337 A5 JP 2017186337A5 JP 2017073900 A JP2017073900 A JP 2017073900A JP 2017073900 A JP2017073900 A JP 2017073900A JP 2017186337 A5 JP2017186337 A5 JP 2017186337A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- chain variable
- variable region
- heavy chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000611 antibody drug conjugate Substances 0.000 claims 29
- 229940049595 antibody-drug conjugate Drugs 0.000 claims 29
- 125000003275 alpha amino acid group Chemical group 0.000 claims 27
- 239000000427 antigen Substances 0.000 claims 21
- 102000036639 antigens Human genes 0.000 claims 21
- 108091007433 antigens Proteins 0.000 claims 21
- 239000012634 fragment Substances 0.000 claims 21
- 102000001760 Notch3 Receptor Human genes 0.000 claims 13
- 108010029756 Notch3 Receptor Proteins 0.000 claims 13
- 206010028980 Neoplasm Diseases 0.000 claims 12
- 201000011510 cancer Diseases 0.000 claims 10
- 239000008194 pharmaceutical composition Substances 0.000 claims 8
- 210000004027 cell Anatomy 0.000 claims 5
- 239000003814 drug Substances 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 238000006467 substitution reaction Methods 0.000 claims 3
- 239000012472 biological sample Substances 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 238000005734 heterodimerization reaction Methods 0.000 claims 2
- 230000036210 malignancy Effects 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 102000039446 nucleic acids Human genes 0.000 claims 2
- 108020004707 nucleic acids Proteins 0.000 claims 2
- 150000007523 nucleic acids Chemical class 0.000 claims 2
- 229920001184 polypeptide Polymers 0.000 claims 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000000523 sample Substances 0.000 claims 2
- 230000011664 signaling Effects 0.000 claims 2
- 238000002560 therapeutic procedure Methods 0.000 claims 2
- NFGXHKASABOEEW-UHFFFAOYSA-N 1-methylethyl 11-methoxy-3,7,11-trimethyl-2,4-dodecadienoate Chemical compound COC(C)(C)CCCC(C)CC=CC(C)=CC(=O)OC(C)C NFGXHKASABOEEW-UHFFFAOYSA-N 0.000 claims 1
- 208000031261 Acute myeloid leukaemia Diseases 0.000 claims 1
- 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 claims 1
- 206010005003 Bladder cancer Diseases 0.000 claims 1
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- 101100074828 Caenorhabditis elegans lin-12 gene Proteins 0.000 claims 1
- 206010008342 Cervix carcinoma Diseases 0.000 claims 1
- 208000010833 Chronic myeloid leukaemia Diseases 0.000 claims 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 claims 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
- 208000034578 Multiple myelomas Diseases 0.000 claims 1
- 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 claims 1
- 208000033776 Myeloid Acute Leukemia Diseases 0.000 claims 1
- 102000005650 Notch Receptors Human genes 0.000 claims 1
- 108010070047 Notch Receptors Proteins 0.000 claims 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 claims 1
- 206010033128 Ovarian cancer Diseases 0.000 claims 1
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 1
- 206010035226 Plasma cell myeloma Diseases 0.000 claims 1
- 208000000453 Skin Neoplasms Diseases 0.000 claims 1
- 208000005718 Stomach Neoplasms Diseases 0.000 claims 1
- 208000029052 T-cell acute lymphoblastic leukemia Diseases 0.000 claims 1
- 208000000389 T-cell leukemia Diseases 0.000 claims 1
- 208000028530 T-cell lymphoblastic leukemia/lymphoma Diseases 0.000 claims 1
- 206010042971 T-cell lymphoma Diseases 0.000 claims 1
- 208000027585 T-cell non-Hodgkin lymphoma Diseases 0.000 claims 1
- 210000001744 T-lymphocyte Anatomy 0.000 claims 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims 1
- 230000001908 autoinhibitory effect Effects 0.000 claims 1
- 210000003719 b-lymphocyte Anatomy 0.000 claims 1
- 201000010881 cervical cancer Diseases 0.000 claims 1
- 238000003776 cleavage reaction Methods 0.000 claims 1
- 230000001268 conjugating effect Effects 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 229940127089 cytotoxic agent Drugs 0.000 claims 1
- 239000002254 cytotoxic agent Substances 0.000 claims 1
- 231100000599 cytotoxic agent Toxicity 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 201000004101 esophageal cancer Diseases 0.000 claims 1
- 206010017758 gastric cancer Diseases 0.000 claims 1
- 201000010536 head and neck cancer Diseases 0.000 claims 1
- 208000014829 head and neck neoplasm Diseases 0.000 claims 1
- 201000005787 hematologic cancer Diseases 0.000 claims 1
- 208000024200 hematopoietic and lymphoid system neoplasm Diseases 0.000 claims 1
- 201000007270 liver cancer Diseases 0.000 claims 1
- 208000014018 liver neoplasm Diseases 0.000 claims 1
- 201000005202 lung cancer Diseases 0.000 claims 1
- 208000020816 lung neoplasm Diseases 0.000 claims 1
- 201000000050 myeloid neoplasm Diseases 0.000 claims 1
- 230000001105 regulatory effect Effects 0.000 claims 1
- 230000007017 scission Effects 0.000 claims 1
- 201000000849 skin cancer Diseases 0.000 claims 1
- 201000004477 skin sarcoma Diseases 0.000 claims 1
- 201000011549 stomach cancer Diseases 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 201000005112 urinary bladder cancer Diseases 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261723772P | 2012-11-07 | 2012-11-07 | |
| US61/723,772 | 2012-11-07 | ||
| US201361889744P | 2013-10-11 | 2013-10-11 | |
| US61/889,744 | 2013-10-11 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015540262A Division JP2016505513A (ja) | 2012-11-07 | 2013-11-04 | 抗ｎｏｔｃｈ３抗体および抗体−薬物コンジュゲート |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017186337A JP2017186337A (ja) | 2017-10-12 |
| JP2017186337A5 true JP2017186337A5 (enExample) | 2017-11-24 |
Family
ID=49585464
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015540262A Pending JP2016505513A (ja) | 2012-11-07 | 2013-11-04 | 抗ｎｏｔｃｈ３抗体および抗体−薬物コンジュゲート |
| JP2017073900A Withdrawn JP2017186337A (ja) | 2012-11-07 | 2017-04-03 | 抗ｎｏｔｃｈ３抗体および抗体−薬物コンジュゲート |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015540262A Pending JP2016505513A (ja) | 2012-11-07 | 2013-11-04 | 抗ｎｏｔｃｈ３抗体および抗体−薬物コンジュゲート |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US9433687B2 (enExample) |
| EP (1) | EP2917240A1 (enExample) |
| JP (2) | JP2016505513A (enExample) |
| KR (1) | KR20150082548A (enExample) |
| CN (1) | CN104903351A (enExample) |
| AR (1) | AR093377A1 (enExample) |
| AU (1) | AU2013343045A1 (enExample) |
| BR (1) | BR112015010436A2 (enExample) |
| CA (1) | CA2890571A1 (enExample) |
| HK (1) | HK1214282A1 (enExample) |
| IL (1) | IL238567A0 (enExample) |
| MX (1) | MX2015005810A (enExample) |
| PE (1) | PE20150892A1 (enExample) |
| PH (1) | PH12015501000A1 (enExample) |
| RU (1) | RU2015116480A (enExample) |
| SA (1) | SA515360395B1 (enExample) |
| SG (1) | SG11201503469WA (enExample) |
| TW (3) | TW201726746A (enExample) |
| WO (1) | WO2014072897A1 (enExample) |
Families Citing this family (80)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20150335438A1 (en) | 2006-02-27 | 2015-11-26 | Biomet Manufacturing, Llc. | Patient-specific augments |
| US8407067B2 (en) | 2007-04-17 | 2013-03-26 | Biomet Manufacturing Corp. | Method and apparatus for manufacturing an implant |
| US9339278B2 (en) | 2006-02-27 | 2016-05-17 | Biomet Manufacturing, Llc | Patient-specific acetabular guides and associated instruments |
| US8608749B2 (en) | 2006-02-27 | 2013-12-17 | Biomet Manufacturing, Llc | Patient-specific acetabular guides and associated instruments |
| US10278711B2 (en) | 2006-02-27 | 2019-05-07 | Biomet Manufacturing, Llc | Patient-specific femoral guide |
| US9173661B2 (en) | 2006-02-27 | 2015-11-03 | Biomet Manufacturing, Llc | Patient specific alignment guide with cutting surface and laser indicator |
| US7967868B2 (en) | 2007-04-17 | 2011-06-28 | Biomet Manufacturing Corp. | Patient-modified implant and associated method |
| US8377066B2 (en) | 2006-02-27 | 2013-02-19 | Biomet Manufacturing Corp. | Patient-specific elbow guides and associated methods |
| US8591516B2 (en) | 2006-02-27 | 2013-11-26 | Biomet Manufacturing, Llc | Patient-specific orthopedic instruments |
| US8608748B2 (en) | 2006-02-27 | 2013-12-17 | Biomet Manufacturing, Llc | Patient specific guides |
| US9345548B2 (en) | 2006-02-27 | 2016-05-24 | Biomet Manufacturing, Llc | Patient-specific pre-operative planning |
| US9907659B2 (en) | 2007-04-17 | 2018-03-06 | Biomet Manufacturing, Llc | Method and apparatus for manufacturing an implant |
| US9918740B2 (en) | 2006-02-27 | 2018-03-20 | Biomet Manufacturing, Llc | Backup surgical instrument system and method |
| US8603180B2 (en) | 2006-02-27 | 2013-12-10 | Biomet Manufacturing, Llc | Patient-specific acetabular alignment guides |
| US8568487B2 (en) | 2006-02-27 | 2013-10-29 | Biomet Manufacturing, Llc | Patient-specific hip joint devices |
| US8092465B2 (en) | 2006-06-09 | 2012-01-10 | Biomet Manufacturing Corp. | Patient specific knee alignment guide and associated method |
| US9289253B2 (en) | 2006-02-27 | 2016-03-22 | Biomet Manufacturing, Llc | Patient-specific shoulder guide |
| US8535387B2 (en) | 2006-02-27 | 2013-09-17 | Biomet Manufacturing, Llc | Patient-specific tools and implants |
| US9113971B2 (en) | 2006-02-27 | 2015-08-25 | Biomet Manufacturing, Llc | Femoral acetabular impingement guide |
| US9795399B2 (en) | 2006-06-09 | 2017-10-24 | Biomet Manufacturing, Llc | Patient-specific knee alignment guide and associated method |
| ES2413087T3 (es) * | 2006-06-13 | 2013-07-15 | Oncomed Pharmaceuticals, Inc. | Composiciones y métodos para el diagnóstico y tratamiento del cáncer |
| CN101511181B (zh) * | 2006-07-11 | 2013-08-21 | 新泽西医科和牙科大学 | 蛋白、编码该蛋白的核酸和相关的应用方法 |
| US9458465B2 (en) | 2007-12-04 | 2016-10-04 | Rutgers, The State University Of New Jersey | Compositions and methods to modulate cell membrane resealing |
| GB2442441B (en) * | 2006-10-03 | 2011-11-09 | Biomet Uk Ltd | Surgical instrument |
| JP5618544B2 (ja) | 2007-01-24 | 2014-11-05 | オンコメッドファーマシューティカルズ インコーポレイテッド | 癌の診断および処置のための組成物および方法 |
| ME02069B (me) | 2008-07-08 | 2015-05-20 | Oncomed Pharm Inc | Vezujuci agensi notch1 receptora i postupci njihove primene |
| DE102009028503B4 (de) | 2009-08-13 | 2013-11-14 | Biomet Manufacturing Corp. | Resektionsschablone zur Resektion von Knochen, Verfahren zur Herstellung einer solchen Resektionsschablone und Operationsset zur Durchführung von Kniegelenk-Operationen |
| US8632547B2 (en) | 2010-02-26 | 2014-01-21 | Biomet Sports Medicine, Llc | Patient-specific osteotomy devices and methods |
| US9271744B2 (en) | 2010-09-29 | 2016-03-01 | Biomet Manufacturing, Llc | Patient-specific guide for partial acetabular socket replacement |
| US8420338B2 (en) | 2010-11-05 | 2013-04-16 | University Of Medicine And Dentistry Of New Jersey | Serum MG53 as a diagnostic marker for tissue injury |
| US9968376B2 (en) | 2010-11-29 | 2018-05-15 | Biomet Manufacturing, Llc | Patient-specific orthopedic instruments |
| US9241745B2 (en) | 2011-03-07 | 2016-01-26 | Biomet Manufacturing, Llc | Patient-specific femoral version guide |
| US8715289B2 (en) | 2011-04-15 | 2014-05-06 | Biomet Manufacturing, Llc | Patient-specific numerically controlled instrument |
| US8956364B2 (en) | 2011-04-29 | 2015-02-17 | Biomet Manufacturing, Llc | Patient-specific partial knee guides and other instruments |
| US8668700B2 (en) | 2011-04-29 | 2014-03-11 | Biomet Manufacturing, Llc | Patient-specific convertible guides |
| AU2012254213A1 (en) * | 2011-05-11 | 2013-11-28 | Riesbeck Healthcare Sweden Ab | Protein F - a novel Haemophilus influenzae adhesin with laminin and vitronectin binding properties |
| US8532807B2 (en) | 2011-06-06 | 2013-09-10 | Biomet Manufacturing, Llc | Pre-operative planning and manufacturing method for orthopedic procedure |
| US9084618B2 (en) | 2011-06-13 | 2015-07-21 | Biomet Manufacturing, Llc | Drill guides for confirming alignment of patient-specific alignment guides |
| US8764760B2 (en) | 2011-07-01 | 2014-07-01 | Biomet Manufacturing, Llc | Patient-specific bone-cutting guidance instruments and methods |
| US8597365B2 (en) | 2011-08-04 | 2013-12-03 | Biomet Manufacturing, Llc | Patient-specific pelvic implants for acetabular reconstruction |
| US9295497B2 (en) | 2011-08-31 | 2016-03-29 | Biomet Manufacturing, Llc | Patient-specific sacroiliac and pedicle guides |
| US9066734B2 (en) | 2011-08-31 | 2015-06-30 | Biomet Manufacturing, Llc | Patient-specific sacroiliac guides and associated methods |
| US9386993B2 (en) | 2011-09-29 | 2016-07-12 | Biomet Manufacturing, Llc | Patient-specific femoroacetabular impingement instruments and methods |
| US9451973B2 (en) | 2011-10-27 | 2016-09-27 | Biomet Manufacturing, Llc | Patient specific glenoid guide |
| US9301812B2 (en) | 2011-10-27 | 2016-04-05 | Biomet Manufacturing, Llc | Methods for patient-specific shoulder arthroplasty |
| KR20130046337A (ko) | 2011-10-27 | 2013-05-07 | 삼성전자주식회사 | 멀티뷰 디바이스 및 그 제어방법과, 디스플레이장치 및 그 제어방법과, 디스플레이 시스템 |
| US9554910B2 (en) | 2011-10-27 | 2017-01-31 | Biomet Manufacturing, Llc | Patient-specific glenoid guide and implants |
| ES2635542T3 (es) | 2011-10-27 | 2017-10-04 | Biomet Manufacturing, Llc | Guías glenoideas específicas para el paciente |
| US9060788B2 (en) | 2012-12-11 | 2015-06-23 | Biomet Manufacturing, Llc | Patient-specific acetabular guide for anterior approach |
| US9204977B2 (en) | 2012-12-11 | 2015-12-08 | Biomet Manufacturing, Llc | Patient-specific acetabular guide for anterior approach |
| PL2935330T3 (pl) * | 2012-12-19 | 2019-11-29 | Aveo Pharmaceuticals Inc | Przeciwciała przeciw notch3 |
| US9839438B2 (en) | 2013-03-11 | 2017-12-12 | Biomet Manufacturing, Llc | Patient-specific glenoid guide with a reusable guide holder |
| US9579107B2 (en) | 2013-03-12 | 2017-02-28 | Biomet Manufacturing, Llc | Multi-point fit for patient specific guide |
| US9498233B2 (en) | 2013-03-13 | 2016-11-22 | Biomet Manufacturing, Llc. | Universal acetabular guide and associated hardware |
| US9826981B2 (en) | 2013-03-13 | 2017-11-28 | Biomet Manufacturing, Llc | Tangential fit of patient-specific guides |
| CN105246916A (zh) * | 2013-03-14 | 2016-01-13 | 诺华股份有限公司 | 针对notch 3的抗体 |
| US9683039B2 (en) * | 2013-03-14 | 2017-06-20 | New York University | Notch agonists for the treatment of cancer |
| US9517145B2 (en) | 2013-03-15 | 2016-12-13 | Biomet Manufacturing, Llc | Guide alignment system and method |
| US20150112349A1 (en) | 2013-10-21 | 2015-04-23 | Biomet Manufacturing, Llc | Ligament Guide Registration |
| US10282488B2 (en) | 2014-04-25 | 2019-05-07 | Biomet Manufacturing, Llc | HTO guide with optional guided ACL/PCL tunnels |
| US9408616B2 (en) | 2014-05-12 | 2016-08-09 | Biomet Manufacturing, Llc | Humeral cut guide |
| SG11201609739UA (en) * | 2014-05-28 | 2016-12-29 | Agensys Inc | Derivatives of dolaproine-dolaisoleuine peptides |
| US9839436B2 (en) | 2014-06-03 | 2017-12-12 | Biomet Manufacturing, Llc | Patient-specific glenoid depth control |
| US9561040B2 (en) | 2014-06-03 | 2017-02-07 | Biomet Manufacturing, Llc | Patient-specific glenoid depth control |
| KR102506663B1 (ko) | 2014-09-28 | 2023-03-08 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | 자극성 및 비자극성 골수성 세포의 조절 |
| US9833245B2 (en) | 2014-09-29 | 2017-12-05 | Biomet Sports Medicine, Llc | Tibial tubercule osteotomy |
| US9826994B2 (en) | 2014-09-29 | 2017-11-28 | Biomet Manufacturing, Llc | Adjustable glenoid pin insertion guide |
| WO2016055907A1 (en) * | 2014-10-10 | 2016-04-14 | Pfizer Inc. | Synergistic auristatin combinations |
| US9820868B2 (en) | 2015-03-30 | 2017-11-21 | Biomet Manufacturing, Llc | Method and apparatus for a pin apparatus |
| US10568647B2 (en) | 2015-06-25 | 2020-02-25 | Biomet Manufacturing, Llc | Patient-specific humeral guide designs |
| US10226262B2 (en) | 2015-06-25 | 2019-03-12 | Biomet Manufacturing, Llc | Patient-specific humeral guide designs |
| WO2017190025A1 (en) * | 2016-04-29 | 2017-11-02 | Aveo Pharmaceuticals, Inc. | Anti-notch3 antibody |
| CN105968038A (zh) * | 2016-05-09 | 2016-09-28 | 湖北华世通生物医药科技有限公司 | 二肽类化合物的盐酸盐及其制备方法 |
| US10722310B2 (en) | 2017-03-13 | 2020-07-28 | Zimmer Biomet CMF and Thoracic, LLC | Virtual surgery planning system and method |
| US10858443B2 (en) | 2017-05-31 | 2020-12-08 | Trustees Of Boston University | Synthetic notch protein for modulating gene expression |
| AU2018383709B2 (en) | 2017-12-12 | 2025-09-11 | Pionyr Immunotherapeutics, Inc. | Anti-TREM2 antibodies and related methods |
| CN108753833B (zh) * | 2018-05-28 | 2021-12-03 | 上海海洋大学 | 斑马鱼notch3基因突变体的制备方法 |
| WO2019242505A1 (zh) | 2018-06-17 | 2019-12-26 | 上海健信生物医药科技有限公司 | 靶向cldn18.2的抗体、双特异性抗体、adc和car及其应用 |
| WO2025011561A1 (en) * | 2023-07-10 | 2025-01-16 | Wuxi Xdc (Shanghai) Co., Ltd. | Antibody-drug conjugates and production thereof |
| WO2025149667A1 (en) | 2024-01-12 | 2025-07-17 | Pheon Therapeutics Ltd | Antibody drug conjugates and uses thereof |
Family Cites Families (70)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| JPS6147500A (ja) | 1984-08-15 | 1986-03-07 | Res Dev Corp Of Japan | キメラモノクロ−ナル抗体及びその製造法 |
| EP0173494A3 (en) | 1984-08-27 | 1987-11-25 | The Board Of Trustees Of The Leland Stanford Junior University | Chimeric receptors by dna splicing and expression |
| GB8422238D0 (en) | 1984-09-03 | 1984-10-10 | Neuberger M S | Chimeric proteins |
| JPS61134325A (ja) | 1984-12-04 | 1986-06-21 | Teijin Ltd | ハイブリツド抗体遺伝子の発現方法 |
| JPS63501765A (ja) | 1985-11-01 | 1988-07-21 | インタ−ナショナル、ジェネティック、エンジニアリング インコ−ポレ−テッド | 抗体遺伝子のモジュ−ル組立体、それにより産生された抗体及び用途 |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| US20030229208A1 (en) | 1988-12-28 | 2003-12-11 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
| US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| ATE158021T1 (de) | 1990-08-29 | 1997-09-15 | Genpharm Int | Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper |
| US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
| US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| AU3178993A (en) | 1991-11-25 | 1993-06-28 | Enzon, Inc. | Multivalent antigen-binding proteins |
| US5786158A (en) | 1992-04-30 | 1998-07-28 | Yale University | Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids |
| WO1995009864A1 (en) | 1993-10-01 | 1995-04-13 | Teikoku Hormone Mfg. Co., Ltd. | Novel peptide derivative |
| CA2116628A1 (en) | 1994-02-28 | 1995-08-29 | Anne Marie Gisele Joutel | Method for the diagnosis of cadasil |
| US5521284A (en) | 1994-08-01 | 1996-05-28 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Human cancer inhibitory pentapeptide amides and esters |
| KR100408909B1 (ko) | 1995-04-21 | 2004-04-29 | 데이꼬꾸 조끼 세이야꾸 가부시키가이샤 | 신규펩티드유도체 |
| EP0780478A1 (en) | 1995-12-21 | 1997-06-25 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Method for the indirect genotypic diagnosis of cadasil |
| WO1997034631A1 (en) | 1996-03-18 | 1997-09-25 | Board Of Regents, The University Of Texas System | Immunoglobin-like domains with increased half lives |
| FR2751986B1 (fr) | 1996-08-01 | 1998-12-31 | Inst Nat Sante Rech Med | Gene implique dans le cadasil, methode de diagnostic et application therapeutique |
| US5985837A (en) | 1998-07-08 | 1999-11-16 | Basf Aktiengesellschaft | Dolastatin 15 derivatives |
| AU768269B2 (en) | 1998-10-02 | 2003-12-04 | Government of The United States of America, as represented by The Secretary Department of Health & Human Services, The National Institutes of Health, The | Apoptosis inducing agents and methods |
| US6323315B1 (en) | 1999-09-10 | 2001-11-27 | Basf Aktiengesellschaft | Dolastatin peptides |
| US6884869B2 (en) | 2001-04-30 | 2005-04-26 | Seattle Genetics, Inc. | Pentapeptide compounds and uses related thereto |
| WO2003020934A1 (en) | 2001-08-31 | 2003-03-13 | Diadexus, Inc. | Compositions and methods relating to colon specific genes and proteins |
| JP2005518785A (ja) | 2001-11-14 | 2005-06-30 | ロランティス リミテッド | 内科療法 |
| EP1448599A2 (en) | 2001-11-14 | 2004-08-25 | Lorantis Limited | Inhibitors of the notch signalling pathway for use in the treatment of cancer |
| US20050137130A1 (en) | 2001-11-14 | 2005-06-23 | Bodmer Mark W. | Medical treatment |
| WO2004001004A2 (en) | 2002-06-21 | 2003-12-31 | Johns Hopkins University School Of Medicine | Membrane associated tumor endothelium markers |
| US20070224201A1 (en) | 2002-10-02 | 2007-09-27 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
| AU2003284357A1 (en) | 2002-11-01 | 2004-06-07 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
| ES2456325T3 (es) | 2003-11-06 | 2014-04-22 | Seattle Genetics, Inc. | Compuestos de monometilvalina capaces de conjugación con ligandos |
| US7282203B2 (en) | 2003-11-26 | 2007-10-16 | Health Research, Inc. | Use of NOTCH pathway interfering agents for treatment of plasma cell disorders |
| US20070077245A1 (en) | 2004-08-04 | 2007-04-05 | The Brigham And Women's Hospital, Inc. | NOTCH mutations leading to increased receptor signaling |
| WO2006053063A2 (en) | 2004-11-05 | 2006-05-18 | The Regents Of The University Of California | Notch-1 assay to detect neurodegenerative diseases |
| JP5167473B2 (ja) | 2005-03-03 | 2013-03-21 | コヴェックス・テクノロジーズ・アイルランド・リミテッド | 抗血管新生化合物 |
| WO2007008848A2 (en) | 2005-07-07 | 2007-01-18 | Seattle Genetics, Inc. | Monomethylvaline compounds having phenylalanine carboxy modifications at the c-terminus |
| US20090305310A1 (en) | 2005-11-22 | 2009-12-10 | University Of Vermont And State Agricultural College | Methods for Determining Notch Signaling and Uses Thereof |
| US7750116B1 (en) | 2006-02-18 | 2010-07-06 | Seattle Genetics, Inc. | Antibody drug conjugate metabolites |
| US8133857B2 (en) | 2006-03-07 | 2012-03-13 | The Brigham and Women's FHospital, Inc. | NOTCH inhibition in the treatment of atherosclerosis |
| US20080241150A1 (en) * | 2006-05-15 | 2008-10-02 | The Brigham And Women's Hospital, Inc. | Functional negative regulatory domain sequences from human NOTCH1 and 2 and isolated LNR domains from human NOTCH1 |
| RU2461569C2 (ru) * | 2006-10-19 | 2012-09-20 | Дженентек, Инк. | Агонистические антитела против notch3 и их применение для лечения notch3-ассоциированных заболеваний |
| UA102061C2 (ru) | 2006-10-19 | 2013-06-10 | Дженентек, Інк. | Агонистическое антитело к notch3 и его применение для лечения notch3- ассоциированных заболеваний |
| MX2009003938A (es) | 2006-10-27 | 2009-04-24 | Genentech Inc | Anticuerpos e inmunoconjugados y sus usos. |
| KR101568049B1 (ko) * | 2006-12-18 | 2015-11-11 | 제넨테크, 인크. | 항-ｎｏｔｃｈ3 길항제 항체 및 ｎｏｔｃｈ3-관련 질환의 예방 및 치료에 있어서 그의 용도 |
| US7807630B2 (en) | 2007-09-14 | 2010-10-05 | Vanderbilt University | Targeting of Notch3 receptor function for cancer therapy |
| EP2211885B1 (en) | 2007-10-12 | 2015-07-29 | Seattle Genetics, Inc. | Combination therapy with antibody-drug conjugates |
| US8609105B2 (en) | 2008-03-18 | 2013-12-17 | Seattle Genetics, Inc. | Auristatin drug linker conjugates |
| JP2011516520A (ja) | 2008-04-07 | 2011-05-26 | アブリンクス エン．ヴェー． | Ｎｏｔｃｈ経路に指向性を有するアミノ酸配列及びその使用 |
| ME02069B (me) | 2008-07-08 | 2015-05-20 | Oncomed Pharm Inc | Vezujuci agensi notch1 receptora i postupci njihove primene |
| AU2010245011B2 (en) | 2009-04-27 | 2015-09-03 | Oncomed Pharmaceuticals, Inc. | Method for making heteromultimeric molecules |
| WO2010141249A2 (en) * | 2009-06-02 | 2010-12-09 | Merck Sharp & Dohme Corp. | Generation, characterization and uses thereof of anti-notch3 antibodies |
| EP3431501A1 (en) | 2009-06-18 | 2019-01-23 | Pfizer Inc | Anti notch-1 antibodies |
| WO2011041336A2 (en) * | 2009-09-30 | 2011-04-07 | Genentech, Inc. | Methods of treating cancer using notch antagonists |
| WO2011140295A2 (en) | 2010-05-06 | 2011-11-10 | President And Fellows Of Harvard College | Modulators of notch receptor signaling and methods of use thereof |
| KR20130050966A (ko) | 2010-07-12 | 2013-05-16 | 씨오브이엑스 테크놀로지스 아일랜드 리미티드 | 다기능적 항체 접합체 |
| US20140121123A1 (en) | 2010-10-29 | 2014-05-01 | Kevin Caili Wang | Methods for diversifying antibodies, antibodies derived therefrom and uses thereof |
| WO2012059882A2 (en) | 2010-11-05 | 2012-05-10 | Rinat Neuroscience Corporation | Engineered polypeptide conjugates and methods for making thereof using transglutaminase |
| US9603894B2 (en) | 2010-11-08 | 2017-03-28 | President And Fellows Of Harvard College | Materials presenting notch signaling molecules to control cell behavior |
| WO2012080891A1 (en) | 2010-12-15 | 2012-06-21 | Rinat Neuroscience Corp. | Anti-notch-1 antibodies |
| CN105884896A (zh) | 2010-12-15 | 2016-08-24 | 惠氏有限责任公司 | 抗缺刻蛋白1抗体 |
| CA2862798C (en) | 2011-02-17 | 2021-04-06 | The Administrators Of The Tulane Educational Fund | Multicomponent compositions and their uses |
| KR101529810B1 (ko) * | 2011-04-01 | 2015-06-26 | 와이어쓰 엘엘씨 | 항체-약물 접합체 |
| MX352738B (es) * | 2011-11-17 | 2017-12-06 | Pfizer | Peptidos citotoxicos y conjugados de anticuerpo-farmaco de los mismos. |
| WO2013093809A1 (en) | 2011-12-23 | 2013-06-27 | Pfizer Inc. | Engineered antibody constant regions for site-specific conjugation and methods and uses therefor |
-
2013
- 2013-11-04 KR KR1020157015019A patent/KR20150082548A/ko not_active Abandoned
- 2013-11-04 WO PCT/IB2013/059893 patent/WO2014072897A1/en not_active Ceased
- 2013-11-04 CN CN201380069303.2A patent/CN104903351A/zh active Pending
- 2013-11-04 BR BR112015010436A patent/BR112015010436A2/pt not_active IP Right Cessation
- 2013-11-04 RU RU2015116480A patent/RU2015116480A/ru not_active Application Discontinuation
- 2013-11-04 SG SG11201503469WA patent/SG11201503469WA/en unknown
- 2013-11-04 TW TW106112626A patent/TW201726746A/zh unknown
- 2013-11-04 EP EP13792099.7A patent/EP2917240A1/en not_active Ceased
- 2013-11-04 AU AU2013343045A patent/AU2013343045A1/en not_active Abandoned
- 2013-11-04 JP JP2015540262A patent/JP2016505513A/ja active Pending
- 2013-11-04 MX MX2015005810A patent/MX2015005810A/es unknown
- 2013-11-04 CA CA2890571A patent/CA2890571A1/en active Pending
- 2013-11-04 PE PE2015000604A patent/PE20150892A1/es not_active Application Discontinuation
- 2013-11-04 TW TW104121691A patent/TWI589590B/zh not_active IP Right Cessation
- 2013-11-04 HK HK16102254.9A patent/HK1214282A1/zh unknown
- 2013-11-04 TW TW102139960A patent/TW201431880A/zh unknown
- 2013-11-06 US US14/073,273 patent/US9433687B2/en not_active Expired - Fee Related
- 2013-11-06 AR ARP130104060A patent/AR093377A1/es unknown
-
2015
- 2015-04-30 IL IL238567A patent/IL238567A0/en unknown
- 2015-05-05 PH PH12015501000A patent/PH12015501000A1/en unknown
- 2015-05-06 SA SA515360395A patent/SA515360395B1/ar unknown
-
2016
- 2016-07-27 US US15/221,049 patent/US20170014526A1/en not_active Abandoned
-
2017
- 2017-04-03 JP JP2017073900A patent/JP2017186337A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017186337A5 (enExample) | ||
| JP2016505513A5 (enExample) | ||
| RU2015116480A (ru) | Анти-notch3 антитела и конъюганты антител с лекарственным средством | |
| JP6215429B2 (ja) | Ｃｄ３８を特異的に認識する抗体とシクロホスファミドとを含有する抗腫瘍組合せ | |
| JP2020501531A5 (enExample) | ||
| JP2015534578A5 (enExample) | ||
| JP2017522871A5 (enExample) | ||
| JP2010535713A5 (enExample) | ||
| JP2017534253A5 (enExample) | ||
| RU2014138038A (ru) | Фармацевтическая композиция для лечения профилактики рака | |
| RU2014101669A (ru) | Агенты, связывающие белки r-спондины (rspo), и способы их применения | |
| JP2020502271A5 (enExample) | ||
| JP2015534577A5 (enExample) | ||
| JP2012529281A5 (enExample) | ||
| JP2017515792A5 (enExample) | ||
| JP2010531140A5 (enExample) | ||
| RU2013142004A (ru) | Конъюгаты "антитело-лекарственное средство" | |
| JP2020509027A5 (enExample) | ||
| TW202446426A (zh) | 抗her3抗體-藥物結合物之用途 | |
| JP2017519759A5 (enExample) | ||
| RU2016117810A (ru) | Конъюгаты белок-полимер-лекарственное средство | |
| JP2013502913A5 (enExample) | ||
| JP2016502504A5 (enExample) | ||
| JP2017522861A5 (enExample) | ||
| JP2021500055A5 (enExample) |